CAS: 449811-92-1

R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.

6-(2,4-Difluorophenoxy)-8-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one is a synthetic organic compound, specifically a pyrido[2,3-d]pyrimidine derivative. It is designed through organic synthesis processes that involve strategic modifications to achieve specific chemical characteristics. The compound acts primarily as an inhibitor within various biochemical pathways, targeting specific molecular interactions involved in pathological conditions. This compound finds applications in therapeutic research, particularly as a potential candidate for pharmacological intervention in diseases where modulation of its target pathways is advantageous. Researchers often explore its efficacy and specificity in preclinical models, aiming to elucidate its role in disease amelioration. The versatility of this compound within drug discovery exemplifies the intersection of chemical innovation and biological application, offering potential insights into treatments for various disorders. As research progresses, in-depth studies continue to uncover the potential mechanisms and therapeutic indices of this sophisticated chemical entity.

R1487